NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
16.41
+0.01 (0.06%)
At close: Dec 20, 2024, 4:00 PM
16.51
+0.10 (0.61%)
After-hours: Dec 20, 2024, 6:31 PM EST
NeoGenomics Market Cap
NeoGenomics has a market cap or net worth of $2.11 billion as of December 20, 2024. Its market cap has decreased by -7.88% in one year.
Market Cap
2.11B
Enterprise Value
2.32B
1-Year Change
-7.88%
Ranking
Category
Stock Price
$16.41
Market Cap Chart
Since March 16, 2004, NeoGenomics's market cap has increased from $7.90M to $2.11B, an increase of 26,563.32%. That is a compound annual growth rate of 30.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.11B | 2.13% |
| Dec 29, 2023 | 2.06B | 76.73% |
| Dec 30, 2022 | 1.17B | -72.22% |
| Dec 31, 2021 | 4.20B | -29.72% |
| Dec 31, 2020 | 5.98B | 95.74% |
| Dec 31, 2019 | 3.05B | 160.37% |
| Dec 31, 2018 | 1.17B | 64.64% |
| Dec 29, 2017 | 712.40M | 5.87% |
| Dec 30, 2016 | 672.90M | 41.66% |
| Dec 31, 2015 | 475.00M | 89.92% |
| Dec 31, 2014 | 250.10M | 41.06% |
| Dec 31, 2013 | 177.30M | 57.88% |
| Dec 31, 2012 | 112.30M | 85.62% |
| Dec 30, 2011 | 60.50M | 24.49% |
| Dec 31, 2010 | 48.60M | -12.90% |
| Dec 31, 2009 | 55.80M | 189.12% |
| Dec 31, 2008 | 19.30M | -43.07% |
| Dec 31, 2007 | 33.90M | -16.30% |
| Dec 29, 2006 | 40.50M | 841.86% |
| Dec 30, 2005 | 4.30M | -20.37% |
| Dec 31, 2004 | 5.40M | -31.65% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 2.18B |
| CONMED | 2.16B |
| Ligand Pharmaceuticals | 2.15B |
| IDEAYA Biosciences | 2.14B |
| Beam Therapeutics | 2.14B |
| LeMaitre Vascular | 2.07B |
| GeneDx Holdings | 2.07B |
| Premier | 2.07B |